These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38513598)

  • 1. Dexmedetomidine attenuates lipopolysaccharide-induced renal cell fibrotic phenotypic changes by inhibiting necroinflammation via activating α
    Sun Q; Kamath P; Sun Y; Liang M; Wu L; Chang E; Chen Q; Alam A; Liu Y; Zhao H; Ma D
    Biomed Pharmacother; 2024 May; 174():116462. PubMed ID: 38513598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexmedetomidine attenuates renal fibrosis via α2-adrenergic receptor-dependent inhibition of cellular senescence after renal ischemia/reperfusion.
    Li Q; Chen C; Chen X; Han M; Li J
    Life Sci; 2018 Aug; 207():1-8. PubMed ID: 29729264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5.
    Hsing CH; Lin CF; So E; Sun DP; Chen TC; Li CF; Yeh CH
    Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1443-53. PubMed ID: 22933299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine protects against lipopolysaccharide-induced early acute kidney injury by inhibiting the iNOS/NO signaling pathway in rats.
    Chen Y; Luan L; Wang C; Song M; Zhao Y; Yao Y; Yang H; Ma B; Fan H
    Nitric Oxide; 2019 Apr; 85():1-9. PubMed ID: 30659917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α2-adrenoreceptor modulated FAK pathway induced by dexmedetomidine attenuates pulmonary microvascular hyper-permeability following kidney injury.
    Chen Q; Yi B; Ma J; Ning J; Wu L; Ma D; Lu K; Gu J
    Oncotarget; 2016 Aug; 7(35):55990-56001. PubMed ID: 27463003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexmedetomidine protects against lipopolysaccharide-induced sepsis-associated acute kidney injury via an α7 nAChR-dependent pathway.
    Kang K; Gao Y; Wang SC; Liu HT; Kong WL; Zhang X; Huang R; Qi ZD; Zheng JB; Qu JD; Liu RJ; Liu YS; Wang HL; Yu KJ
    Biomed Pharmacother; 2018 Oct; 106():210-216. PubMed ID: 29960167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dexmedetomidine on lipopolysaccharide-induced acute kidney injury in rats and mitochondrial function in cell culture.
    Kiyonaga N; Moriyama T; Kanmura Y
    Biomed Pharmacother; 2020 May; 125():109912. PubMed ID: 32014689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine attenuates lipopolysaccharide-induced liver oxidative stress and cell apoptosis in rats by increasing GSK-3β/MKP-1/Nrf2 pathway activity via the α2 adrenergic receptor.
    Sha J; Zhang H; Zhao Y; Feng X; Hu X; Wang C; Song M; Fan H
    Toxicol Appl Pharmacol; 2019 Feb; 364():144-152. PubMed ID: 30597158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of α2 adrenoceptor attenuates lipopolysaccharide-induced hepatic injury.
    Chen JH; Yu GF; Jin SY; Zhang WH; Lei DX; Zhou SL; Song XR
    Int J Clin Exp Pathol; 2015; 8(9):10752-9. PubMed ID: 26617786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexmedetomidine alleviates cisplatin‑induced acute kidney injury by attenuating endoplasmic reticulum stress‑induced apoptosis via the α2AR/PI3K/AKT pathway.
    Chai Y; Zhu K; Li C; Wang X; Shen J; Yong F; Jia H
    Mol Med Rep; 2020 Mar; 21(3):1597-1605. PubMed ID: 32016445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexmedetomidine alleviates H
    Yin W; Wang C; Peng Y; Yuan W; Zhang Z; Liu H; Xia Z; Ren C; Qian J
    Mol Biol Rep; 2020 May; 47(5):3629-3639. PubMed ID: 32342432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexmedetomidine Promotes Lipopolysaccharide-Induced Differentiation of Cardiac Fibroblasts and Collagen I/III Synthesis through α
    Liao J; Li K; Su X; Chen Y; Wang Y; Tang X; Xing Y; Xu Y; Dai X; Teng J; Li H; Wang H; Lv X; Wang Y
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexmedetomidine Alleviates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting p75NTR-Mediated Oxidative Stress and Apoptosis.
    Wang Z; Wu J; Hu Z; Luo C; Wang P; Zhang Y; Li H
    Oxid Med Cell Longev; 2020; 2020():5454210. PubMed ID: 33194004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting the NLRP3 inflammasome activation via regulating the TLR4/NOX4/NF-κB pathway.
    Yao Y; Hu X; Feng X; Zhao Y; Song M; Wang C; Fan H
    J Cell Biochem; 2019 Oct; 120(10):18509-18523. PubMed ID: 31243816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine Activates Akt, STAT6 and IRF4 Modulating Cytoprotection and Macrophage Anti-Inflammatory Phenotype Against Acute Lung Injury in vivo and in vitro.
    Chen Q; Qin Z; Sun Y; Liu X; Pac Soo A; Chang E; Sun Q; Yi B; Wang DX; Zhao H; Ma D; Gu J
    J Inflamm Res; 2022; 15():2707-2720. PubMed ID: 35502244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic effect of dexmedetomidine on protection from renal failure via inhibiting KDM5A in lipopolysaccharide-induced sepsis of mice.
    Liu Y; Yu Y; Zhang J; Wang C
    Life Sci; 2019 Dec; 239():116868. PubMed ID: 31682847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexmedetomidine ameliorates lipopolysaccharide-induced acute kidney injury in rats by inhibiting inflammation and oxidative stress via the GSK-3β/Nrf2 signaling pathway.
    Feng X; Guan W; Zhao Y; Wang C; Song M; Yao Y; Yang T; Fan H
    J Cell Physiol; 2019 Aug; 234(10):18994-19009. PubMed ID: 30919976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexmedetomidine Preconditioning Protects Rats from Renal Ischemia-Reperfusion Injury Accompanied with Biphasic Changes of Nuclear Factor-Kappa B Signaling.
    Bao N; Tang B; Wang J
    J Immunol Res; 2020; 2020():3230490. PubMed ID: 32377532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation.
    Liang H; Liu HZ; Wang HB; Zhong JY; Yang CX; Zhang B
    Inflamm Res; 2017 May; 66(5):399-411. PubMed ID: 28224201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexmedetomidine alleviates pulmonary edema through the epithelial sodium channel (ENaC) via the PI3K/Akt/Nedd4-2 pathway in LPS-induced acute lung injury.
    Jiang Y; Xia M; Xu J; Huang Q; Dai Z; Zhang X
    Immunol Res; 2021 Apr; 69(2):162-175. PubMed ID: 33641076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.